Separability of Acute Cerebral Infarction Lesions in CT Based Radiomics: Toward Artificial Intelligence-Assisted Diagnosis.

Journal: BioMed research international
Published Date:

Abstract

This study aims at analyzing the separability of acute cerebral infarction lesions which were invisible in CT. 38 patients, who were diagnosed with acute cerebral infarction and performed both CT and MRI, and 18 patients, who had no positive finding in either CT or MRI, were enrolled. Comparative studies were performed on lesion and symmetrical regions, normal brain and symmetrical regions, lesion, and normal brain regions. MRI was reconstructed and affine transformed to obtain accurate lesion position of CT. Radiomic features and information gain were introduced to capture efficient features. Finally, 10 classifiers were established with selected features to evaluate the effectiveness of analysis. 1301 radiomic features were extracted from candidate regions after registration. For lesion and their symmetrical regions, there were 280 features with information gain greater than 0.1 and 2 features with information gain greater than 0.3. The average classification accuracy was 0.6467, and the best classification accuracy was 0.7748. For normal brain and their symmetrical regions, there were 176 features with information gain greater than 0.1, 1 feature with information gain greater than 0.2. The average classification accuracy was 0.5414, and the best classification accuracy was 0.6782. For normal brain and lesions, there were 501 features with information gain greater than 0.1 and 1 feature with information gain greater than 0.5. The average classification accuracy was 0.7480, and the best classification accuracy was 0.8694. In conclusion, the study captured significant features correlated with acute cerebral infarction and confirmed the separability of acute lesions in CT, which established foundation for further artificial intelligence-assisted CT diagnosis.

Authors

  • Yun Guan
    North University of China-Taiyuan Central Hospital Joint Innovation Institute, 3 Xueyuan Road, Taiyuan, Shanxi 030051, China.
  • Peng Wang
    Neuroengineering Laboratory, School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
  • Qi Wang
    Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Peihao Li
    School of Information and Communication Engineering, North University of China, 3 Xueyuan Road, Taiyuan, Shanxi 030051, China.
  • Jianchao Zeng
    North University of China-Taiyuan Central Hospital Joint Innovation Institute, 3 Xueyuan Road, Taiyuan, Shanxi 030051, China.
  • Pinle Qin
    North University of China-Taiyuan Central Hospital Joint Innovation Institute, 3 Xueyuan Road, Taiyuan, Shanxi 030051, China.
  • Yanfeng Meng
    North University of China-Taiyuan Central Hospital Joint Innovation Institute, 3 Xueyuan Road, Taiyuan, Shanxi 030051, China.